Vilja Pietiäinen

University of Helsinki — Finland

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index2.4kcitations75works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Lipids, and Metabolism(12), Cell Image Analysis Techniques(11), Estrogen and related hormone effects(9), 3D Printing in Biomedical Research(8), Metabolomics and Mass Spectrometry Studies(7)

Publications75 total

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology
npj Precision Oncology·2026Open Access
Image-based profiling of healthy donor immune cells with Blood Cell Painting
2025
High-content Image-based Drug Testing of Patients’ Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma
Acta Dermato Venereologica·2025Open Access
Genome sequencing reveals <i>CCDC88A</i> variants in malformations of cortical development and immune dysfunction
Human Molecular Genetics·2025Open Access
Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma
npj Precision Oncology·2025· 2 citedOpen Access
Exploiting <scp>NRF2</scp>‐<scp>ARE</scp> pathway activation in papillary renal cell carcinoma
International Journal of Cancer·2024· 2 citedOpen Access
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma
Communications Biology·2024· 2 citedOpen Access
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses
OncoImmunology·2024· 6 citedOpen Access
Abstract B016: Unravelling personalized drug vulnerabilities in pediatric solid tumors—functional precision medicine approach
Cancer Research·2024
Image-based profiling of healthy donor immune cells with Blood Cell Painting reveals novel genotype-phenotype associations
2024· 2 citedOpen Access
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome
Antiviral Research·2024· 8 citedOpen Access
Distinct Molecular Profiles and Drug Vulnerabilities in Pancreatic Metastases of Renal Cell Carcinoma
2023Open Access
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2
Cell Reports Methods·2023· 7 citedOpen Access
OTHR-04. DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM
Neuro-Oncology·2023Open Access
Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT)
SLAS DISCOVERY·2023· 15 citedOpen Access
Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets
European Urology Focus·2023· 7 citedOpen Access
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
npj Precision Oncology·2022· 55 citedOpen Access
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
British Journal of Cancer·2022· 25 citedOpen Access
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates
SLAS DISCOVERY·2022· 7 citedOpen Access
Image-based &amp; machine learning-guided multiplexed serology test for SARS-CoV-2
2022Open Access
page 1 of 4Next →

Frequent Co-authors

Olli Kallioniemi(22), Lassi Paavolainen(17), Elina Ikonen(11), Antti Hassinen(10), Laura Turunen(10), Péter Horváth(9), Piia Mikkonen(9), Swapnil Potdar(9), Susanne Hultsch(7), Matti Kankainen(7), Sara Kangaspeska(7), Michaela Feodoroff(7), Ruusu‐Maaria Kovanen(6), Astrid Murumägi(6), Päivi Östling(5), Timo Hyypiä(5), Jani Saarela(5), Minttu Polso(5), Katja Välimäki(5), Teijo Pellinen(5)